A complete application in a minute
Tailored resume and cover letter, ready to send.
Vaxxinova US is seeking a Financial Analyst to join the finance team in Willmar or Worthington, Minnesota. This full-time role partners with multiple functions, preparing financial models and dashboards to drive business visibility and support the budgeting process.
The analyst will leverage Power BI, ERP systems, and standard costing principles to deliver insights, while maintaining confidentiality and supporting audits. Growth opportunities and a strong benefits package accompany the position.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Full Time Worthington, MN, US
3 days ago Requisition ID: 1200
Salary Range: $70,000.00 To $105,000.00 Annually
Vaxxinova US is seeking an individual to join our finance team as a Financial Analyst in Willmar or Worthington, Minnesota.
At Vaxxinova US, you’ll be part of a passionate team dedicated to making a difference. We offer competitive pay and benefits, opportunities for growth, and a supportive work culture.
About the role: The Financial Analyst will work closely with all areas of the business and act as a Business Partner. They will help bring visibility to the business through the creation of models and dashboards while also assisting in the creation of the budget.
Main Responsibilities:
Qualifications and Capabilities:
Experience/Educational Requirements:
Schedule
Benefits at Vaxxinova:
We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Most benefits begin on date of hire. Our benefits include:
About Vaxxinova
Vaxxinova provides a wide range of both autogenous and licensed vaccines combined with high-level diagnostic services, supported by strong R&D. Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands. Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state-of-the-art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. Vaxxinova is part of the family-owned EW Group, headquartered in Germany. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.